Quantum Dot-Based Dual-Color In Situ Fluorescence Imaging of the Coevolution of CD68 and CD47 in Breast Cancer
Source abstract
Abstract
In breast cancer (BC), the tumor microenvironment contains various cell types and extracellular components, of which CD68 and CD47 are two key factors. Recent studies have shown that simultaneous high expression of CD68 and CD47 is associated with poor prognosis in BC. However, there is no direct methodological evidence to support this finding. Here, using our own preparation of different functionalized quantum dots, we successfully achieved dual-color in situ fluorescence imaging of CD68 and CD47 with high spatial resolution. This imaging approach provided directly observable evidence that cancer cells evading immune responses are surrounded by more macrophages, suggesting that the coevolution of CD68 and CD47 during BC development can promote cancer cell metastasis. Taken together, our results provide direct evidence for evaluating prognostic factors of BC and will contribute to our understanding of the tumor microenvironment and its role in tumor evolution.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Phagocytosis and Immune Regulation · Nanoplatforms for cancer theranostics · Immune cells in cancer
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Biosensing and Molecular Recognition, Research Center for Analytical Sciences, College of Chemistry, and School of Medicine, Nankai University, Tianjin 300071, P. R. China
Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China
Funding
Ministry of Education of the People's Republic of China · Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China
References (52)
Show source-provided references
1. 10.3322/caac.2132010.3322/caac.21320 ↗
2. 10.1007/s00404-015-3859-y10.1007/s00404-015-3859-y ↗
3. 10.1016/S0140-6736(16)32417-510.1016/S0140-6736(16)32417-5 ↗
4. 10.1002/adma.20070198310.1002/adma.200701983 ↗
5. 10.1111/j.1349-7006.2011.02183.x10.1111/j.1349-7006.2011.02183.x ↗
6. 10.1038/nature2081510.1038/nature20815 ↗
7. 10.1016/j.ccr.2004.06.01010.1016/j.ccr.2004.06.010 ↗
8. 10.1016/S0140-6736(00)49915-010.1016/S0140-6736(00)49915-0 ↗
9. 10.1016/j.canlet.2016.01.04310.1016/j.canlet.2016.01.043 ↗
10. 10.21147/j.issn.1000-9604.2017.03.1010.21147/j.issn.1000-9604.2017.03.10 ↗
11. 10.3892/ol.2016.501410.3892/ol.2016.5014 ↗
12. 10.3892/ol.2019.1061810.3892/ol.2019.10618 ↗
13. 10.4049/jimmunol.180.4.201110.4049/jimmunol.180.4.2011 ↗
14. 10.1111/imm.1202310.1111/imm.12023 ↗
15. 10.1158/0008-5472.CAN-05-400510.1158/0008-5472.CAN-05-4005 ↗
16. 10.1016/j.it.2004.09.01510.1016/j.it.2004.09.015 ↗
17. 10.1158/0008-5472.CAN-06-182310.1158/0008-5472.CAN-06-1823 ↗
18. 10.1016/j.lungcan.2011.04.00910.1016/j.lungcan.2011.04.009 ↗
19. Quatromoni J. G. · Am. J. Transl. Res. · 2012 · 4 · 376
20. 10.1172/JCI2764810.1172/JCI27648 ↗
21. 10.1073/pnas.112162310910.1073/pnas.1121623109 ↗
22. 10.1155/2013/61461910.1155/2013/614619 ↗
23. 10.1038/ncomms1480210.1038/ncomms14802 ↗
24. 10.1158/1078-0432.CCR-14-252010.1158/1078-0432.CCR-14-2520 ↗
25. 10.1038/nbt.257610.1038/nbt.2576 ↗
26. 10.1073/pnas.152003211210.1073/pnas.1520032112 ↗
27. 10.1186/s12935-019-0957-010.1186/s12935-019-0957-0 ↗
28. 10.1016/j.clinbiochem.2007.05.01810.1016/j.clinbiochem.2007.05.018 ↗
29. 10.1063/1.44721810.1063/1.447218 ↗
30. 10.1103/PhysRevLett.60.53510.1103/PhysRevLett.60.535 ↗
31. 10.1016/j.yexmp.2015.06.01310.1016/j.yexmp.2015.06.013 ↗
32. 10.2147/IJN.S2416110.2147/IJN.S24161 ↗
33. 10.1016/j.bbrc.2011.05.05210.1016/j.bbrc.2011.05.052 ↗
34. 10.2217/nnm.12.910.2217/nnm.12.9 ↗
35. 10.1021/ac201331r10.1021/ac201331r ↗
36. 10.1021/cm070754d10.1021/cm070754d ↗
37. 10.1039/C6RA04987G10.1039/C6RA04987G ↗
38. 10.1073/pnas.180615311510.1073/pnas.1806153115 ↗
39. 10.2217/fon.13.6310.2217/fon.13.63 ↗
40. 10.1021/jp054289o10.1021/jp054289o ↗
41. 10.1021/ja903633d10.1021/ja903633d ↗
42. 10.1039/b909063k10.1039/b909063k ↗
43. 10.1039/C3CP53502A10.1039/C3CP53502A ↗
44. 10.1002/smll.20160230910.1002/smll.201602309 ↗
45. 10.1039/C8NR02017E10.1039/C8NR02017E ↗
46. 10.1021/nn700450g10.1021/nn700450g ↗
47. 10.1021/acsami.7b0955710.1021/acsami.7b09557 ↗
48. 10.1016/j.biomaterials.2010.12.05310.1016/j.biomaterials.2010.12.053 ↗
49. 10.1136/jcp.2005.03117910.1136/jcp.2005.031179 ↗
50. 10.1023/A:101614613076710.1023/A:1016146130767 ↗
51. 10.2353/jmoldx.2007.06018610.2353/jmoldx.2007.060186 ↗
52. 10.1021/nn100213v10.1021/nn100213v ↗